Multiple Mutations in Heterogeneous Miltefosine-Resistant Leishmania major Population as Determined by Whole Genome Sequencing

BACKGROUND: Miltefosine (MF) is the first oral compound used in the chemotherapy against leishmaniasis. Since the mechanism of action of this drug and the targets of MF in Leishmania are unclear, we generated in a step-by-step manner Leishmania major promastigote mutants highly resistant to MF. Two...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Coelho, Adriano C., Boisvert, Sébastien, Mukherjee, Angana, Leprohon, Philippe, Corbeil, Jacques, Ouellette, Marc
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2012
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3279362/
https://ncbi.nlm.nih.gov/pubmed/22348164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0001512
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires